These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 20201996)
1. Prognostic value of serum CA125 levels in diffuse large B-cell lymphoma: potential role of a new sex- and age-adjusted reference value. Gutiérrez A; Martínez-Serra J; Barceló B; Sampol A; Viñas L; González G; Bea MD; Amat JC; Martín J; Ramos R; Bautista A; Forteza-Rey J; Rodríguez J; Besalduch J Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):582-9. PubMed ID: 20201996 [TBL] [Abstract][Full Text] [Related]
2. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis. Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110 [TBL] [Abstract][Full Text] [Related]
3. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. Bonnet C; Beguin Y; Fassotte MF; Seidel L; Luyckx F; Fillet G Eur J Haematol; 2007 May; 78(5):399-404. PubMed ID: 17419741 [TBL] [Abstract][Full Text] [Related]
4. Prognosis of localized diffuse large B-cell lymphoma in younger patients. Møller MB; Christensen BE; Pedersen NT Cancer; 2003 Aug; 98(3):516-21. PubMed ID: 12879468 [TBL] [Abstract][Full Text] [Related]
5. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer. Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084 [TBL] [Abstract][Full Text] [Related]
6. Diffuse large B-cell lymphoma: clinical characterization and prognosis of Waldeyer ring versus lymph node presentation. Qi SN; Li YX; Wang H; Wang WH; Jin J; Song YW; Wang SL; Liu YP; Zhou LQ; Yu ZH Cancer; 2009 Nov; 115(21):4980-9. PubMed ID: 19634158 [TBL] [Abstract][Full Text] [Related]
7. The prognostic value of pre-operative serum tetranectin, CA-125 and a combined index in women with primary ovarian cancer. Høgdall CK; Nørgaard-Pedersen B; Mogensen O Anticancer Res; 2002; 22(3):1765-8. PubMed ID: 12168866 [TBL] [Abstract][Full Text] [Related]
8. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission. Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255 [TBL] [Abstract][Full Text] [Related]
9. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694 [TBL] [Abstract][Full Text] [Related]
10. Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index. Lech-Maranda E; Bienvenu J; Broussais-Guillaumot F; Warzocha K; Michallet AS; Robak T; Coiffier B; Salles G Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):131-41. PubMed ID: 20191326 [TBL] [Abstract][Full Text] [Related]
11. Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas. Guglielmi C; Martelli M; Federico M; Zinzani PL; Vitolo U; Bellesi G; Santini G; Tarella C; Zallio F; Pregno P; Di Renzo N; Resegotti L; Haematologica; 2001 Sep; 86(9):941-50. PubMed ID: 11532622 [TBL] [Abstract][Full Text] [Related]
12. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma. Porrata LF; Ristow K; Habermann TM; Witzig TE; Inwards DJ; Markovic SN Am J Hematol; 2009 Feb; 84(2):93-7. PubMed ID: 19123458 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772 [TBL] [Abstract][Full Text] [Related]
14. Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer. Kang WD; Choi HS; Kim SM Gynecol Oncol; 2010 Jan; 116(1):57-60. PubMed ID: 19818996 [TBL] [Abstract][Full Text] [Related]
15. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity. Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277 [TBL] [Abstract][Full Text] [Related]
16. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy. Kim SJ; Lee SJ; Choi IY; Park Y; Choi CW; Kim IS; Yu W; Hwang HS; Kim BS Eur J Haematol; 2008 Sep; 81(3):177-84. PubMed ID: 18510703 [TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics, cell origin and prognosis of primary gastrointestinal diffuse large B-cell lymphoma: a report of 40 cases]. Yang YL; Wang J; Zhao LZ; Gao ZF; Jing HM; Ke XY Ai Zheng; 2008 Jun; 27(6):636-41. PubMed ID: 18570740 [TBL] [Abstract][Full Text] [Related]
19. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients]. Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923 [TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma]. Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]